▣ ScanRecallsGet the app ↗

VERIFIED OFFICIAL-SOURCE INDEX

Current Product Recalls in United Kingdom – Page 7

Browse official recall notices for United Kingdom, then compare the product and every listed identifier with the item you own.

Last updated: October 12, 2026 at 10:03 AM UTC · Official sources are checked throughout the day.

Check your product by barcode, model or lot →

SCAN ONCE. KEEP WATCHING.

Keep an eye on the products at home.

Scan food and household product barcodes, save your items and get notified when a future recall may match.

Download on the App StoreGet it on Google Play

328 current and recent recalls

Showing 241–280 of 328 notices · Page 7 of 9

Medicines and Healthcare products Regulatory Agency · July 23, 2026

Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby Recall: Neuraxpharm UK Ltd has informed

Affected product
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby
Category
Medical device recalls
Hazard
Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and 40mg chewable tablets.
Check affected Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby identifiers →

Food Standards Scotland · July 22, 2026

Food alert 22 July 2026 Graham’s Family Dairy Graham’s Family Dairy Recall: The presence of veterinary

Affected product
Food alert 22 July 2026 Graham’s Family Dairy Graham’s Family Dairy
Category
Food recalls
Hazard
The presence of veterinary medicines, including antibiotics in the product may make it unsafe to consume and may be a possible health risk for anyone with an allergy to antibiotics including penicillin. Our advice to consumers: If you have bought the above…
Check affected Food alert 22 July 2026 Graham’s Family Dairy Graham’s Family Dairy identifiers →

Food Standards Scotland · July 21, 2026

Food alert 21 July 2026 Farmfoods packs of 8 Farmfoods Quarter Recall: Causes of food poisoning Food

Affected product
Food alert 21 July 2026 Farmfoods packs of 8 Farmfoods Quarter
Category
Food recalls
Hazard
Causes of food poisoning Food incidents Food crime Contaminants in food Novel foods Buying food on social media Food labels Food labels Use by and best before date labels Nutritional labels Food Hygiene Information Scheme Know the food facts Know the food…
Check affected Food alert 21 July 2026 Farmfoods packs of 8 Farmfoods Quarter identifiers →

Medicines and Healthcare products Regulatory Agency · July 20, 2026

Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd Recall: Macarthys Laboratories Ltd T/A

Affected product
Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd
Category
Medical device recalls
Hazard
Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in the bottles.
Check affected Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd identifiers →

Medicines and Healthcare products Regulatory Agency · July 13, 2026

Class 2 Medicines : Beckton Dickson UK Ltd, ChloraPrep 1mL Recall: Becton Dickinson UK Ltd are recalling

Affected product
Class 2 Medicines : Beckton Dickson UK Ltd, ChloraPrep 1mL
Category
Medical device recalls
Hazard
Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators due to a potential breach of sterility in the packaging process.
Check affected Class 2 Medicines : Beckton Dickson UK Ltd, ChloraPrep 1mL identifiers →

Medicines and Healthcare products Regulatory Agency · July 9, 2026

Class 2 Medicines : Bristol Laboratories Limited Recall: Bristol Laboratories Limited is recalling one batch

Affected product
Class 2 Medicines : Bristol Laboratories Limited
Category
Medical device recalls
Hazard
Bristol Laboratories Limited is recalling one batch (7124002) of Phenoxymethylpenicillin 250 mg/5 ml Oral Solution Sugar Free due to product labelling issues.
Check affected Class 2 Medicines : Bristol Laboratories Limited identifiers →

Medicines and Healthcare products Regulatory Agency · June 30, 2026

Class 3 Medicines : Flamingo Pharma UK Ltd, Flucloxacillin Capsules Recall: Flamingo Pharma UK Ltd have

Affected product
Class 3 Medicines : Flamingo Pharma UK Ltd, Flucloxacillin Capsules
Category
Medical device recalls
Hazard
Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL for Flucloxacillin BP 500mg Capsules.
Check affected Class 3 Medicines : Flamingo Pharma UK Ltd, Flucloxacillin Capsules identifiers →

Medicines and Healthcare products Regulatory Agency · June 30, 2026

UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited Recall: Relonchem Limited have informed the

Affected product
UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited
Category
Medical device recalls
Hazard
Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint.
Check affected UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited identifiers →

Medicines and Healthcare products Regulatory Agency · June 29, 2026

Class 4 Medicines Defect Notification: Brancaster Pharma Limited Recall: Brancaster Pharma Limited has

Affected product
Class 4 Medicines Defect Notification: Brancaster Pharma Limited
Category
Medical device recalls
Hazard
Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were released with an outdated PIL.
Check affected Class 4 Medicines Defect Notification: Brancaster Pharma Limited identifiers →

Medicines and Healthcare products Regulatory Agency · June 16, 2026

Class 3 Medicines : Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Recall: Orbit Pharma Limited is

Affected product
Class 3 Medicines : Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml
Category
Medical device recalls
Hazard
Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing site.
Check affected Class 3 Medicines : Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml identifiers →

Medicines and Healthcare products Regulatory Agency · June 8, 2026

Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Recall: Cadila Pharmaceuticals Limited has

Affected product
Class 4 Medicines Defect Notification: Cadila Pharmaceuticals
Category
Medical device recalls
Hazard
Cadila Pharmaceuticals Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg Film-Coated Tablets distributed in Crescent Pharma Limited livery.
Check affected Class 4 Medicines Defect Notification: Cadila Pharmaceuticals identifiers →

Medicines and Healthcare products Regulatory Agency · June 4, 2026

Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi Recall: Teva UK Limited is reporting a

Affected product
Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi
Category
Medical device recalls
Hazard
Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to the skin” when the product is licensed for subcutaneous use.
Check affected Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi identifiers →

Medicines and Healthcare products Regulatory Agency · June 2, 2026

Class 2 Medicines : Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and Recall: Becton Dickinson UK Ltd are

Affected product
Class 2 Medicines : Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and
Category
Medical device recalls
Hazard
Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% 1mL applicators and ChloraPrep Frepp 2% 1.5 mL applicators due to a potential breach of sterility in the packaging process.
Check affected Class 2 Medicines : Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and identifiers →

Medicines and Healthcare products Regulatory Agency · May 28, 2026

Class 2 Medicines : Crescent Pharma Limited, Ramipril 2.5 mg Recall: Crescent Pharma Limited is initiating a

Affected product
Class 2 Medicines : Crescent Pharma Limited, Ramipril 2.5 mg
Category
Medical device recalls
Hazard
Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site.
Check affected Class 2 Medicines : Crescent Pharma Limited, Ramipril 2.5 mg identifiers →

Medicines and Healthcare products Regulatory Agency · May 27, 2026

Allurion Gastric Balloon: Updated safety information the risks of Recall: In rare instances, the Allurion

Affected product
Allurion Gastric Balloon: Updated safety information the risks of
Category
Medical device recalls
Hazard
In rare instances, the Allurion Gastric Balloon has not transited through the stomach or bowel as intended, leading to complications such as gastric outlet obstruction, small bowel obstruction and gastric perforation.
Check affected Allurion Gastric Balloon: Updated safety information the risks of identifiers →

Medicines and Healthcare products Regulatory Agency · May 20, 2026

severe harm from use of incorrect giving (administration) set for Recall: There is a potential for serious

Affected product
severe harm from use of incorrect giving (administration) set for
Category
Medical device recalls
Hazard
There is a potential for serious harm to patients if an intravenous (IV) infusion giving set is used instead of a blood transfusion giving set to deliver a transfusion of blood or blood components.
Check affected severe harm from use of incorrect giving (administration) set for identifiers →

Medicines and Healthcare products Regulatory Agency · May 19, 2026

Kimal Procedure Packs containing recalled components: Namic Recall: Medline Industries LP and Kimal PLC have

Affected product
Kimal Procedure Packs containing recalled components: Namic
Category
Medical device recalls
Hazard
Medline Industries LP and Kimal PLC have identified safety issues with the Namic Angiographic Control Syringes with RA and Namic White Star Off Handle Manifold devices, and have issued field safety notices to affected UK hospitals advising that they should not…
Check affected Kimal Procedure Packs containing recalled components: Namic identifiers →

Medicines and Healthcare products Regulatory Agency · May 11, 2026

Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide Recall: Milpharm Limited has identified

Affected product
Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide
Category
Medical device recalls
Hazard
Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.
Check affected Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide identifiers →

Medicines and Healthcare products Regulatory Agency · April 28, 2026

Class 2 Medicines : Amarox Limited, Sertraline 100mg film-coated Recall: of more pronounced serotonergic

Affected product
Class 2 Medicines : Amarox Limited, Sertraline 100mg film-coated
Category
Medical device recalls
Hazard
of more pronounced serotonergic effects. The risk is however higher in patients with pre-existing cardiac conditions, those aged over 65 years, or those taking concomitant serotonergic or QT prolonging medication. Additionally, as some patients may require…
Check affected Class 2 Medicines : Amarox Limited, Sertraline 100mg film-coated identifiers →

Medicines and Healthcare products Regulatory Agency · April 22, 2026

Class 4 Medicines Defect Notification: Doncaster Pharma Limited Recall: of dosing errors arising from the

Affected product
Class 4 Medicines Defect Notification: Doncaster Pharma Limited
Category
Medical device recalls
Hazard
of dosing errors arising from the Braille issue. Advice for Patients: No action is needed from patients, continue to take medication from these batches of tablets. The actions will be controlled by the healthcare professionals who prescribe or dispense the…
Check affected Class 4 Medicines Defect Notification: Doncaster Pharma Limited identifiers →

Browse product recalls by year

Download on the App StoreGet it on Google Play